CGT Catapult pitches ‘federation’ to lower cell and gene therapy development costs at Meeting on the Mesa
Stephen Ward, chief technology officer of the UK’s Cell and Gene Therapy Catapult, told Meeting on the Mesa that developers can share data, testbeds and manufacturing space without losing control.